Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Science, Biology & Dosimetry

Optimization of astatine(211At) imaging for dosimetry in clinical trial using multidetector cadmium zinc telluride (CZT) SPECT/CT

Takashi Kamiya, Tadashi Watabe, Sadahiro Naka, Hidetaka Sasaki, Kaede Tsuzura, Koshi Kotani, Kazuhiro Ooe, Kayako Isohashi and Koichi Fujino
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 24106;
Takashi Kamiya
1Osaka University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tadashi Watabe
2Osaka University Graduate School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sadahiro Naka
2Osaka University Graduate School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hidetaka Sasaki
1Osaka University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaede Tsuzura
1Osaka University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koshi Kotani
1Osaka University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuhiro Ooe
3Osaka University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kayako Isohashi
3Osaka University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koichi Fujino
1Osaka University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

24106

Introduction: 211At (half-life: 7.2 hours) is an alpha-emitter which can be used for the targeted alpha therapy in thyroid cancer. In the investigator-initiated clinical trial using 211At, whole-body image acquisition of distribution is essential for estimating absorbed doses. These images require the quantitative accuracy and reproducibility of pixel values for dose estimation, particularly in relation to the time-activity changes after administration. In the present study, we assessed the 211At image quality simulating 3 and 24 hours after administration using multi CZT detector SPECT/CT.

Methods: VERITON-CT (Spectrum Dynamics Medical) was employed in this phantom study. Energy window was set as 79 keV ± 20% targeting the characteristic X-rays emitted from the daughter nuclide of 211Po (half-life: 0.52 seconds). Scan duration was set as 18 minutes/bed, simulating whole-body SPECT acquisition from head to pelvis (3 beds) within one hour in a patient scenario. SPECT acquisition was performed with the ratio of hot sphere to background radioactivity set at 8:1 (radioactivity concentration approximately 17.6-2.2 kBq/mL and 2.4-0.3 kBq/mL, respectively). The reconstruction parameters (number of iterations and subsets, full width at half maximum (FWHM) of Gaussian filter (GF)) were optimized by the analysis of the SPECT images with reference to the guidelines for standardization of bone SPECT imaging 1.0 from the Japanese Society of Nuclear Medicine Technology and Japanese guideline for the oncology FDG-PET/CT data acquisition protocol. The SPECT images were assessed for differences across various subsets, iterations, and GF settings through %contrast (: Q17mm > 11%), background noise (: N17mm < 10%), contrast-to-noise ratio, recovery coefficient and visual analysis with consensus from board-certified nuclear medicine physicians.

Results: For the SPECT images at 3 hours, Q17mm and N17mm with subsets:8, iterations:6 and GF:5 mm were 16.1 and 9.1%, respectively. The SPECT images with above reconstruction parameters satisfied the threshold of the guideline, however at 24hours, N17mm increased to 26.7% due to less acquisition counts. Instead of GF with 10 mm, N17mm at 24 hours decreased to 13.7% and visual assessment of 17 mm sphere was improved to detect.

Conclusions: From this phantom based research, the 211At SPECT images using multidetector CZT SPECT/CT scanner were optimized as well as diagnostic bone SPECT images be done. Optimal reconstruction parameters for dosimetry until 3 hours were iterations:6, subsets:8 and GF:5 mm. For those until 24 hours, GF should be changed to 10 mm.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Optimization of astatine(211At) imaging for dosimetry in clinical trial using multidetector cadmium zinc telluride (CZT) SPECT/CT
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Optimization of astatine(211At) imaging for dosimetry in clinical trial using multidetector cadmium zinc telluride (CZT) SPECT/CT
Takashi Kamiya, Tadashi Watabe, Sadahiro Naka, Hidetaka Sasaki, Kaede Tsuzura, Koshi Kotani, Kazuhiro Ooe, Kayako Isohashi, Koichi Fujino
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 24106;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Optimization of astatine(211At) imaging for dosimetry in clinical trial using multidetector cadmium zinc telluride (CZT) SPECT/CT
Takashi Kamiya, Tadashi Watabe, Sadahiro Naka, Hidetaka Sasaki, Kaede Tsuzura, Koshi Kotani, Kazuhiro Ooe, Kayako Isohashi, Koichi Fujino
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 24106;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Evaluating the Effectiveness of Treating Renal Cell Carcinoma with SIRT
  • Comparison of purification methods for [13N]NH3 production
Show more Radiopharmaceutical Science, Biology & Dosimetry

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire